Obstetrics & Gynecology at Renji Hospital Shanghai | CMCS

Expert Women's Health Care at One of Shanghai's Premier Hospitals

The Department of Obstetrics and Gynecology at Renji Hospital — affiliated with Shanghai Jiao Tong University School of Medicine — is one of Shanghai's most distinguished women's health centers, with a national reputation for excellence in high-risk obstetrics, minimally invasive gynecological surgery, gynecologic oncology, urogynecology, and the management of complex obstetric and gynecological conditions. The department combines outstanding clinical expertise with a world-class research program and a fully integrated multidisciplinary approach, offering international patients access to some of China's most eminent obstetricians and gynecologists and the latest evidence-based treatments and surgical techniques.

For international patients seeking expert obstetric care during a high-risk pregnancy, minimally invasive gynecological surgery, treatment for gynecologic cancer, or management of a complex gynecological condition in Shanghai — Renji Hospital's obstetrics and gynecology department offers an unparalleled combination of clinical expertise, surgical capability, and research leadership. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their care journey at Renji Hospital.

About the Department

Renji Hospital's obstetrics and gynecology department is a national key clinical specialty operating dedicated obstetric and gynecological wards, a labor and delivery suite, a maternal-fetal medicine (MFM) unit, a neonatal intensive care unit (NICU) in close collaboration with neonatology, a minimally invasive gynecological surgery program with da Vinci robotic surgical capability, a gynecologic oncology service, a urogynecology and pelvic floor clinic, an endometriosis center, and works in close collaboration with reproductive medicine, oncology, urology, and neonatology through a fully integrated multidisciplinary team.

Faculty members publish regularly in leading obstetrics and gynecology journals including American Journal of Obstetrics and Gynecology, BJOG, Obstetrics & Gynecology, Gynecologic Oncology, and Human Reproduction.

Obstetrics & Maternal-Fetal Medicine

High-Risk Obstetrics

• Advanced Maternal Age (AMA) — Comprehensive prenatal screening; cell-free DNA (cfDNA/NIPT) for chromosomal aneuploidy; detailed anomaly scan; genetic counseling; optimized delivery planning
• Preeclampsia & Hypertensive Disorders — Low-dose aspirin prophylaxis for high-risk patients; antihypertensive therapy (labetalol, nifedipine, methyldopa); magnesium sulfate for severe preeclampsia and eclampsia prevention; timing of delivery optimization
• Gestational Diabetes Mellitus (GDM) — Dietary management; insulin therapy; continuous glucose monitoring; fetal surveillance; postpartum diabetes screening
• Preterm Labor & Preterm Birth Prevention — Cervical length screening; progesterone supplementation; cervical cerclage; tocolysis (nifedipine, atosiban); antenatal corticosteroids; magnesium sulfate for neuroprotection
• Placenta Previa & Placenta Accreta Spectrum (PAS) — MRI for PAS diagnosis; multidisciplinary delivery planning (obstetrics, urology, interventional radiology, blood bank); cesarean hysterectomy; uterine artery embolization; cell salvage
• Fetal Growth Restriction (FGR) — Doppler surveillance; timing of delivery; neonatal resuscitation preparation
• Multiple Pregnancy — Dichorionic and monochorionic twin management; TTTS (twin-to-twin transfusion syndrome) fetoscopic laser ablation; selective fetal growth restriction in monochorionic twins
• Antiphospholipid Syndrome in Pregnancy — Low-dose aspirin + LMWH; hydroxychloroquine; close fetal surveillance
• Autoimmune Disease in Pregnancy — SLE, rheumatoid arthritis, and other autoimmune conditions in pregnancy; coordination with Renji's rheumatology department; neonatal lupus monitoring
• Cardiac Disease in Pregnancy — Coordination with cardiology for congenital and acquired heart disease in pregnancy; multidisciplinary delivery planning

Fetal Medicine

• Prenatal Diagnosis — First-trimester combined screening; NIPT/cfDNA for trisomy 21, 18, 13, and sex chromosome aneuploidies; detailed anomaly scan at 20-22 weeks; fetal echocardiography; amniocentesis and chorionic villus sampling (CVS)
• Fetal Therapy — Fetoscopic laser ablation for TTTS; intrauterine transfusion for fetal anemia (anti-D, anti-Kell); fetal pleural drainage; amnioreduction for polyhydramnios
• Fetal Anomaly Counseling — Multidisciplinary counseling for fetal structural anomalies; prognosis and postnatal management planning; coordination with pediatric surgery, cardiology, and neurology

Labor & Delivery

• Vaginal Birth — Evidence-based labor management; continuous electronic fetal monitoring; epidural analgesia; water birth for selected patients; active management of third stage
• Cesarean Section — Primary and repeat cesarean; gentle cesarean (family-centered cesarean); VBAC (vaginal birth after cesarean) for selected patients
• Operative Vaginal Delivery — Vacuum and forceps delivery for selected indications
• Postpartum Hemorrhage (PPH) Management — Oxytocin; tranexamic acid; uterine balloon tamponade; B-Lynch suture; uterine artery ligation; interventional radiology; cell salvage

Gynecology

Minimally Invasive Gynecological Surgery

• Robotic-Assisted Gynecological Surgery — Robotic myomectomy for uterine fibroids; robotic hysterectomy; robotic sacrocolpopexy for pelvic organ prolapse; robotic endometriosis excision; robotic staging for gynecologic cancer
• Laparoscopic Surgery — Laparoscopic hysterectomy (TLH, LAVH); laparoscopic myomectomy; laparoscopic ovarian cystectomy; laparoscopic salpingectomy and salpingo-oophorectomy; laparoscopic treatment of ectopic pregnancy; laparoscopic endometriosis excision
• Hysteroscopic Surgery — Hysteroscopic myomectomy for submucosal fibroids; hysteroscopic polypectomy; hysteroscopic adhesiolysis for Asherman's syndrome; hysteroscopic septum resection; endometrial ablation

Endometriosis & Adenomyosis

• Endometriosis — Laparoscopic excision of endometriosis (preferred over ablation); deep infiltrating endometriosis (DIE) surgery; endometrioma cystectomy; medical management (GnRH agonists, dienogest, elagolix, relugolix); fertility-sparing surgery; coordination with reproductive medicine for IVF
• Adenomyosis — Medical management (GnRH agonists, LNG-IUS, dienogest); adenomyomectomy for focal adenomyosis; uterine artery embolization; high-intensity focused ultrasound (HIFU); hysterectomy for severe symptomatic adenomyosis

Uterine Fibroids

• Medical Management — GnRH agonists for pre-operative shrinkage; ulipristal acetate; relugolix; LNG-IUS for menorrhagia
• Minimally Invasive Treatment — Robotic and laparoscopic myomectomy; hysteroscopic myomectomy for submucosal fibroids; uterine artery embolization (UAE); HIFU for selected patients
• Hysterectomy — Robotic and laparoscopic hysterectomy for definitive treatment

Gynecologic Oncology

• Cervical Cancer — Radical hysterectomy (robotic and laparoscopic); sentinel lymph node biopsy; fertility-sparing radical trachelectomy for early-stage disease; concurrent chemoradiation for locally advanced disease; pembrolizumab + chemoradiation (KEYNOTE-A18); tisotumab vedotin for recurrent/metastatic disease; cemiplimab
• Endometrial Cancer — Robotic staging (hysterectomy + BSO + SLNB); adjuvant chemotherapy and radiation; pembrolizumab + lenvatinib for advanced/recurrent disease; dostarlimab for dMMR endometrial cancer; olaparib for HRD-positive disease; fertility-sparing management with progestins for early-stage grade 1 disease
• Ovarian Cancer — Cytoreductive surgery (primary and interval debulking); carboplatin + paclitaxel; bevacizumab; PARP inhibitors (olaparib, niraparib, rucaparib) for maintenance; mirvetuximab soravtansine for FRα-positive platinum-resistant ovarian cancer; BRCA testing and genetic counseling
• Vulvar & Vaginal Cancer — Surgical excision; sentinel lymph node biopsy; chemoradiation; pembrolizumab for recurrent disease
• Gestational Trophoblastic Disease — Hydatidiform mole management; methotrexate and actinomycin D for low-risk GTN; EMA-CO for high-risk GTN; pembrolizumab for refractory GTN

Urogynecology & Pelvic Floor

• Pelvic Organ Prolapse — Pelvic floor physiotherapy; pessary; robotic sacrocolpopexy; native tissue repair (uterosacral ligament suspension, sacrospinous fixation)
• Stress Urinary Incontinence — Pelvic floor physiotherapy; mid-urethral sling (TVT, TOT); Burch colposuspension; urethral bulking agents
• Overactive Bladder — Behavioral therapy; antimuscarinics; beta-3 agonists (mirabegron, vibegron); botulinum toxin; sacral neuromodulation
• Fistula Repair — Vesicovaginal and rectovaginal fistula repair; obstetric fistula

Menstrual & Hormonal Disorders

• Abnormal Uterine Bleeding (AUB) — Systematic PALM-COEIN evaluation; LNG-IUS; tranexamic acid; endometrial ablation; hysterectomy for refractory cases
• Polycystic Ovary Syndrome (PCOS) — Lifestyle modification; metformin; combined oral contraceptives; letrozole for ovulation induction; coordination with reproductive medicine for IVF
• Premature Ovarian Insufficiency (POI) — Hormone replacement therapy; fertility counseling; coordination with reproductive medicine for egg donation IVF
• Menopause Management — Hormone replacement therapy (HRT); non-hormonal options (fezolinetant for vasomotor symptoms); bone health management

Why International Patients Choose Renji Obstetrics & Gynecology

• High-Risk Obstetrics Expertise — Comprehensive MFM program for advanced maternal age, preeclampsia, placenta accreta, and autoimmune disease in pregnancy
• Fetal Medicine — Fetoscopic laser for TTTS; intrauterine transfusion; comprehensive prenatal diagnosis
• Robotic Gynecological Surgery — Robotic myomectomy, hysterectomy, endometriosis excision, and gynecologic cancer staging
• Gynecologic Oncology — Pembrolizumab + chemoradiation for cervical cancer; dostarlimab for dMMR endometrial cancer; PARP inhibitors for ovarian cancer
• Reproductive Medicine Integration — Seamless collaboration with Renji's world-class IVF center for fertility-sparing surgery and post-surgical IVF
• Cost-Effectiveness — World-class women's health care at significantly lower cost than equivalent treatment in Western countries

The CMCS Patient Journey

1. Initial Inquiry — Share your obstetric or gynecological history, ultrasound reports, laboratory results, pathology reports, and current medications with CMCS.
2. Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
3. Specialist Matching — We identify the most appropriate obstetrician or gynecologist based on your condition — high-risk obstetrics, fetal medicine, minimally invasive surgery, gynecologic oncology, or urogynecology.
4. Priority Scheduling — We secure a consultation with minimal waiting time.
5. Travel & Logistics — Assistance with visa invitation letters, accommodation near Renji Hospital, and Shanghai airport transfers.
6. On-Site Concierge — Bilingual coordinators accompany you throughout hospital visits, managing registration, translation, and communication with sensitivity and discretion.
7. Surgical or Delivery Coordination — Full coordination of pre-operative assessment, surgical admission, or delivery planning.
8. Post-Care Follow-Up — Pathology report translation, treatment plan interpretation, and remote follow-up coordination after you return home.

Book a Consultation

If you are seeking expert obstetric care during a high-risk pregnancy, minimally invasive gynecological surgery, treatment for gynecologic cancer, or management of a complex gynecological condition — CMCS can arrange a specialist consultation with Renji Hospital's obstetrics and gynecology team in Shanghai.

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com